Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
3 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).

COVID-19 in pregnancy characterized by nonspecific symptoms, prolonged disease course

12 Nov 2020

Not as many pregnant women with COVID-19 present with fever, but a lot of them experience fatigue, body aches, and headaches as compared with women not carrying a child, a study has found.

Furthermore, pregnancy appears to contribute to a prolonged course of disease for some women, whereby symptoms persist for 8 weeks or more after disease onset.

In total, 991 women in the US who had known or suspected SARS-CoV-2 infection were examined in the study. Average gestational age at enrollment was 24.1 weeks, and 13 percent of women were enrolled after pregnancy.

Of the women, 736 had symptoms of COVID-19 at the time of testing, with 594 testing positive and 142 negative. Their mean age was 31.3 years, and 37 percent were nulliparous.

The women who tested positive for SARS-CoV-2-infection had a diverse geographical representation: 34 percent were from the northeast, 25 percent from the west, 21 percent from the south, and 18 percent from the midwest. Thirty-one percent of the population were Latina, and 9 percent were black.

In the SARS-CoV-2 positive cohort, cough (20 percent) was the most prevalent first symptom. This was followed by sore throat (16 percent), body aches (12 percent), and fever (12 percent). Median time to symptom resolution was 37 days. The symptoms persisted 8 weeks after onset in 25 percent of the women.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
3 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).